Abstract

FDAMA Proposed List of Agents Not to be Compounded due to Withdrawal for Safety/Efficacy Concerns

Author(s): Allen Loyd V Jr

Issue: Jan/Feb 1999 - Dental Compounding

Page(s): 25-29

Download in electronic PDF format for $75

Abstract

The US Food and Drug Administration has proposed that drug products listed in the table provided here be included on the list of drug products withdrawn or removed from the market because they have been found to be unsafe or ineffective. Therefore, compounding a drug product on this list would not be covered by the exemption provided in Section 503A(a) of the Federal Food and Drug Administration Modernization Act of 1997. The list originally appeared in the October 8, 1998, Federal Register (63[195]:54083-54087). Listings are mostly alphabetical. Reasons for withdrawal and withdrawal dates are also provided.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jan/Feb 1999 Pg. 25-29	FDAMA Proposed List of Agents Not to be Compounded due to Withdrawal for Safety/Efficacy Concerns Author(s): Allen Loyd V Jr
Nov/Dec 2020 Pg. 451-458	Safety Standards in Pharmaceutical Compounding, Part 3: Fire Safety Author(s): Allen W Chris, Greeson Nicole MH, Mixon William
Jul/Aug 2004 Pg. 313-319	Efficacy and Tolerability of Compounded Bioidentical Hormone Replacement Therapy Author(s): Vigesaa Kristy A, Downhour Nathan P, Chui Michelle A, Cappellini Linda, Musil John D, McCallian Dennis J
Jul/Aug 2001 Pg. 310-312	Wetting and/or Solubilizing Agents, Featured Excipient: Author(s): Allen Loyd V Jr
Sep/Oct 2020 Pg. 356	Safety and Efficacy Studies, Pharmacy Education, and the NASEM Report on Compounded Topical Pain Creams Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 270-276	Safety Standards in Pharmaceutical Compounding, Part 1: The Occupational Safety and Health Administration Author(s): Greeson Nicole MH, Mixon William, Allan W Chris
Sep/Oct 2020 Pg. 371-379	Safety Standards in Pharmaceutical Compounding, Part 2: A Closer Look at Agency Information, Oversight, and Assistance Author(s): Greeson Nicole MH, Mixon William, Allan W Chris
Jan/Feb 2015 Pg. 57-58	Basics of Compounding: The Revised "Not to Compound List" Author(s): Allen Loyd V Jr
Mar/Apr 2024 Pg. 111-116	Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review Author(s): Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
Jul/Aug 2015 Pg. 295-300	Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review Author(s): Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
May/Jun 2013 Pg. 182-190	Complying with Occupational Safety and Health Administration Regulations: A Guide for Compounding Pharmacists Author(s): Mixon Bill, Nain John
Sep/Oct 2018 Pg. 387-398	Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations Author(s): Ashe Krystina, Baskett Dustin
May/Jun 2019 Pg. 182-186	How to Develop and Maintain a Hazardous Drug List Author(s): Dillon L Rad
Mar/Apr 2017 Pg. 118-124	Quality Control: (Material) Safety Data Sheets Author(s): Allen Loyd V Jr
Jan/Feb 2002 Pg. 60-61	Safety for Employees in the Compounding Work Area Author(s): Allen Loyd V Jr
Nov/Dec 2013 Pg. 485-489	Quality Control Analytical Methods: A Growing Codependency: Compounding Pharmacy and Safety Author(s): Prince Bryan, Lundeval Jeremy
Sep/Oct 2021 Pg. 358-362	Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA Author(s): Cabaleiro Joe
Jan/Feb 2015 Pg. 6-12	Efficacy and Clinical Value of Commonly Compounded Hormone Replacement Therapy: A Literature Review Author(s): Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
Nov/Dec 2016 Pg. 477-479	The "Lists": What Do They Mean? Author(s): Voliva John
Jul/Aug 2015 Pg. 311-313	Basics of Compounding: The "Negative" List Author(s): Allen Loyd V